GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SOC Telemed Inc (NAS:TLMDW) » Definitions » Return-on-Tangible-Equity

SOC Telemed (SOC Telemed) Return-on-Tangible-Equity : 0.00% (As of Dec. 2021)


View and export this data going back to 2020. Start your Free Trial

What is SOC Telemed Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. SOC Telemed's annualized net income for the quarter that ended in Dec. 2021 was $-50.54 Mil. SOC Telemed's average shareholder tangible equity for the quarter that ended in Dec. 2021 was $-9.17 Mil. Therefore, SOC Telemed's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2021 was N/A%.

The historical rank and industry rank for SOC Telemed's Return-on-Tangible-Equity or its related term are showing as below:

TLMDW's Return-on-Tangible-Equity is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 10.62
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

SOC Telemed Return-on-Tangible-Equity Historical Data

The historical data trend for SOC Telemed's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SOC Telemed Return-on-Tangible-Equity Chart

SOC Telemed Annual Data
Trend Dec19 Dec20 Dec21
Return-on-Tangible-Equity
- - -

SOC Telemed Semi-Annual Data
Dec19 Dec20 Dec21
Return-on-Tangible-Equity - - -

Competitive Comparison of SOC Telemed's Return-on-Tangible-Equity

For the Medical Care Facilities subindustry, SOC Telemed's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SOC Telemed's Return-on-Tangible-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SOC Telemed's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where SOC Telemed's Return-on-Tangible-Equity falls into.



SOC Telemed Return-on-Tangible-Equity Calculation

SOC Telemed's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2021 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2021 )  (A: Dec. 2020 )(A: Dec. 2021 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2021 )  (A: Dec. 2020 )(A: Dec. 2021 )
=-50.542/( (23.862+-42.2 )/ 2 )
=-50.542/-9.169
=N/A %

SOC Telemed's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2021 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Dec. 2021 )  (Q: Dec. 2020 )(Q: Dec. 2021 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Dec. 2021 )  (Q: Dec. 2020 )(Q: Dec. 2021 )
=-50.542/( (23.862+-42.2)/ 2 )
=-50.542/-9.169
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is one times the annual (Dec. 2021) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


SOC Telemed  (NAS:TLMDW) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


SOC Telemed Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of SOC Telemed's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


SOC Telemed (SOC Telemed) Business Description

Traded in Other Exchanges
N/A
Address
1768 Business Center Drive, Suite 100, Reston, VA, USA, 20190
SOC Telemed Inc is a provider of acute care telemedicine services and technology to U.S. hospitals and healthcare systems based on number of clients. It provides technology enabled clinical solutions which include acute teleNeurology, telePsychiatry, and teleICU, and telePulmonology service. It supports specialty care, providing time-sensitive specialty care when patients are vulnerable and may not otherwise have access. Its solution was developed to support complex workflows in the acute care setting by integrating cloud-based software platform, Telemed IQ, with a panel of patient advocates and a network of clinical specialists to create a seamless, acute telemedicine solution.
Executives
David R. Fletcher officer: Interim CFO C/O SOC TELEMED, INC., 1768 BUSINESS CENTER DRIVE, SUITE 100, RESTON VA 20190
David Mikula officer: Chief Operating Officer C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Gyasi C. Chisley director C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Christopher M. Gallagher director C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Steven J Shulman director 1564 NE EXPRESSWAY, ATTN: BJ PURCELL, ATLANTA GA 30329
Christopher K Knibb officer: Chief Financial Officer C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Warburg Pincus Partners Ii, L.p. director, 10 percent owner 450 LEXINGTON AVENUE, C/O WARBURG PINCUS LLC, NEW YORK NY 10017
Anne Mcgeorge director C/O MAGENTA THERAPEUTICS, INC., 100 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE MA 02139
Wpxi Finance, Lp director, 10 percent owner C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017
Wpxi Gp, L.p. director, 10 percent owner C/O WARBURG PINCUS LLC, 450 LEXINGTON AVE, NEW YORK NY 10017
Warburg Pincus & Co. director, 10 percent owner 450 LEXINGTON AVENUE, NEW YORK, NY NY 100173147
Amr Kronfol director C/O WARBURG PINCUS LLC, 450 LEXINGTON AVE, NEW YORK NY 10017
Joseph P Greskoviak director C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Sean Banerjee officer: Chief Technology Officer C/O SOC TELEMED 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
John W. Kalix director, officer: Chief Executive Officer C/O SOC TELEMED 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190